Table 1.

Characteristics of peritoneal dialysis patients with recurrent gram-positive peritonitis

Patient	Age	Gender			Episode	Peritonitis starting		Infection	Intraperitoneal
no	(year)	(F/M)	Aetiology	PD starting date	number	date	Organisms	types	treatment
1	57	F	Diabetes mellitus	01 February 2005	3	29 December 2006	Culture-negative	–	C
						07 February 2007	Culture-negative	Relapse	C
						16 March 2007	S. aureus	Repeat	C + V^a
2	47	M	Idiopathic	09 March 2005	5	22 December 2006	S. epidermidis	–	C
						30 January 2007	S. epidermidis	Relapse	C
						08 March 2007	S. epidermidis	Relapse	C
						12 April 2007	Culture-negative	Relapse	C
						02 May 2007	Culture-negative	Relapse	C + V^a
3	76	M	Idiopathic	31 December 2004	5	04 December 2006	Culture-negative	–	C
						03 January 2007	S. aureus	Relapse	C
						28 January 2007	Culture-negative	Relapse	C
						11 March 2007	S. epidermidis	Re-infection	C
						12 April 2007	Culture-negative	Relapse	C + V^a
4	54	F	Diabetes mellitus	01 January 2004	4	11 December 2006	S. aureus	–	C
						20 January 2007	S. aureus	Relapse	C
						28 February 2007	S. aureus	Relapse	C
						01 May 2007	S. aureus	Repeat	C + V^a
5	45	F	Idiopathic	01 April 2006	5	12 October 2006	Culture-negative	–	C
						11 November 2006	Corynebacterium	Relapse	C
						29 November 2006	Culture-negative	Relapse	C
						29 January 2007	Culture-negative	Repeat	C
						09 March 2007	S. epidermidis	Re-infection	C + V^a
6	52	F	Idiopathic	07 October 2004	3	01 January 2007	S. hominis	–	C
						21 February 2007	MRSE	Re-infection	V^b
						28 March 2007	Culture-negative	Relapse	C + V^a

F, female; M, male; PD, peritoneal dialysis; MRSE, methicillin-resistant staphylococcus epidermidis; C, cefazolin (a loading dose 500 mg/L and maintenance dose 125 mg/L in all exchanges for 14 to 21 days), V, vancomycin (^aa single dose of 2 g intracatheterial. ^bLoading dose of 2 g and repeat dosing 1 g in long dwell every 7 days).